RxDoctor Payments Data

Michael Oller, MD

Family Medicine · Wichita, KSNPI 1740441906

Payments from drug & device makers

$603in general payments, 2019–2025

Across 37 payments — averaging $16.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sunovion Pharmaceuticals Inc.$190
  • AbbVie$113
  • Johnson & Johnson$62
  • Medtronic$49
  • Amgen$41
  • Insulet Corporation$25
  • plus $122 from 8 others

What the payments were for

  • Food & beverage$603100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$603 in reported general payments places this provider in the 50th percentile of 1,469 family medicine providers in Kansas.

See all family medicine providers in Kansas

Medicare billing

Part B allowed, 2024
$156,129
Medicare patients
568
Services billed
2,342

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BetaseronInterferon Beta-1b12$111,409
EliquisApixaban166$85,734
FarxigaDapagliflozin Propanediol50$32,108
RybelsusSemaglutide18$21,332
OzempicSemaglutide19$18,194
YupelriRevefenacin12$18,142
JardianceEmpagliflozin17$17,211
XareltoRivaroxaban22$16,267
Xultophy 100-3.6Insulin Degludec/Liraglutide12$15,167
InvokanaCanagliflozin13$12,702
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog24$10,799
EntrestoSacubitril/Valsartan16$10,758
MyrbetriqMirabegron26$10,335
JanuviaSitagliptin Phosphate26$7,432
FiaspInsulin Aspart (Niacinamide)15$6,846

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskRybelsus, Ozempic, Xultophy 100-3.6, Fiasp$15$61,53964 claims
Johnson & JohnsonXarelto, Invokana$62$28,96935 claims
Mylan Specialty L.p.Yupelri$13$18,14212 claims
AbbVieSynthroid$113$2,97931 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 1,469 family medicine providers in Kansas.

Other family medicine in Wichita

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →